Aquagenic Pruritus in Myeloproliferative Neoplasms
NCT04018209 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 170
Last updated 2024-11-01
Summary
Description of the characteristics of aquagenic pruritus expressed by patients suffering from myeloproliferative neoplasms.
Prospective work based on the distribution of a dedicated questionnaire.
Conditions
- Deciphering Aquagenic Pruritus in Myeloproliferaitive Neoplasms
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-09
- Primary Completion
- 2020-01-09
- Completion
- 2021-01-06
Countries
- France
Study Locations
More Related Trials
-
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders
NCT00433862 ·Status: COMPLETED
-
Epidemiological and Clinical-pathological Factors of Philadelphia-negative Myeloproliferative Neoplasms in Ecuador
NCT05825326 ·Status: COMPLETED
-
National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia
NCT07019766 ·Status: RECRUITING
-
Role of aGVHD Biomarkers on aGVHD Risks
NCT04284904 ·Status: COMPLETED
-
Survival in Myelofibrosis Patients After Allogeneic Hematopoietic Stem Cell Transplantation in Five Centers in France
NCT04282421 ·Status: COMPLETED
-
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
NCT01890486 ·Status: RECRUITING
-
Study of Cellular Heterogeneity in Patients With Mastocytosis
NCT06432556 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
NCT05012111 ·Status: RECRUITING
-
Progression of Hematopoietic Diseases in Shanghai, China
NCT00365014 ·Status: COMPLETED
-
Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder
NCT00722254 ·Status: TERMINATED
-
National Marrow Donor Program Long-Term Donor Follow-Up
NCT01362179 ·Status: COMPLETED
-
Monoclonal Gammopathy With Clinical Significance in Patients With and Without Haematological Malignancies in Finistère Between 2012 and 2017 (GammaClinik)
NCT06559579 ·Status: COMPLETED
-
The Indiana Myeloma Registry
NCT03616483 ·Status: RECRUITING
-
Umbilical Cord Blood Transfusion in Consolidation Therapy of Elderly Patients With Acute Myeloid Leukemia
NCT04687657 ·Status: UNKNOWN ·Phase: PHASE1
-
Natural Killer Index From Hematopoietic Stem Cell Graft
NCT00435864 ·Status: COMPLETED ·Phase: NA
-
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
NCT05556928 ·Status: RECRUITING
-
Molecular Mechanisms and Diagnosis of Mastocytosis
NCT00336076 ·Status: COMPLETED
-
Screening for Hematology Branch Protocols
NCT00001620 ·Status: ENROLLING_BY_INVITATION
-
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation
NCT06702111 ·Status: RECRUITING
-
Characteristics and Results of Patients Treated by Therapeutic Intensification
NCT06894381 ·Status: RECRUITING
-
aCGH Impacts Survival in Plasma Cell PTLD
NCT02984215 ·Status: COMPLETED
-
A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers
NCT02409121 ·Status: COMPLETED ·Phase: NA
-
Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study
NCT04372524 ·Status: RECRUITING
-
Photopheresis in GvHD After Hematopoietic Transplantation: Characteristics of the Procedure and of the Cell Product
NCT05718674 ·Status: COMPLETED
-
Prognostic Value of Circulating Tumoral DNA After the First 6 Months of Treatment in Patients With Waldenström Macroglobulinemia
NCT04893564 ·Status: RECRUITING ·Phase: NA